» Articles » PMID: 35628145

A MLR-Based Approach to Analyze Regulators of T Lymphocyte Activation In Vivo

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 May 28
PMID 35628145
Authors
Affiliations
Soon will be listed here.
Abstract

Depending on the context, robust and durable T lymphocyte activation is either desirable, as in the case of anti-tumor responses, or unwanted, in cases of autoimmunity when chronic stimulation leads to self-tissue damage. Therefore, reliable in vivo models are of great importance to identify and validate regulatory pathways of T lymphocyte activation. Here, we describe an in vivo mixed-lymphocyte-reaction (MLR) approach, which is based on the so-called parent-into-F1 (P → F1) mouse model in combination with the congenic marker CD45.1/2 and cell proliferation dye-labeling. This setup allows us to track adoptively transferred allogenic CD4 and CD8 T lymphocytes and analyze their phenotype as well as the proliferation by flow cytometry in the blood and spleen. We could show hypo-reactive responses of T lymphocytes isolated from knockout mice with a known defect in T lymphocyte activation. Thus, this MLR-based in vivo model provides the opportunity to analyze positive regulators of T cell responses under physiological conditions of polyclonal T lymphocyte activation in vivo.

Citing Articles

T cell-intrinsic protein kinase D3 is dispensable for the cells' activation.

Koutnik J, Leitges M, Siegmund K Front Immunol. 2022; 13:1049033.

PMID: 36466811 PMC: 9713823. DOI: 10.3389/fimmu.2022.1049033.

References
1.
Via C, Rus V, Nguyen P, Linsley P, Gause W . Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J Immunol. 1996; 157(9):4258-67. View

2.
Hogquist K, Jameson S, Heath W, Howard J, Bevan M, Carbone F . T cell receptor antagonist peptides induce positive selection. Cell. 1994; 76(1):17-27. DOI: 10.1016/0092-8674(94)90169-4. View

3.
Nguyen V, Rus H, Chen C, Rus V . CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model. J Immunol. 2016; 196(4):1529-40. DOI: 10.4049/jimmunol.1501824. View

4.
Chen J, Chang M, Muench M . A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J Immunol Methods. 2003; 279(1-2):123-33. DOI: 10.1016/s0022-1759(03)00236-9. View

5.
Via C . Advances in lupus stemming from the parent-into-F1 model. Trends Immunol. 2010; 31(6):236-45. PMC: 2883015. DOI: 10.1016/j.it.2010.02.001. View